{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:17:37Z","timestamp":1787167057887,"version":"build-2736575974"},"reference-count":120,"publisher":"Bentham Science Publishers Ltd.","issue":"3","funder":[{"DOI":"10.13039\/501100003069","name":"Instituto Politecnico Nacional","doi-asserted-by":"publisher","award":["SIP-2017 0207"],"award-info":[{"award-number":["SIP-2017 0207"]}],"id":[{"id":"10.13039\/501100003069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003069","name":"Instituto Politecnico Nacional","doi-asserted-by":"publisher","award":["2018 0306"],"award-info":[{"award-number":["2018 0306"]}],"id":[{"id":"10.13039\/501100003069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003069","name":"Instituto Politecnico Nacional","doi-asserted-by":"publisher","award":["2019 0295"],"award-info":[{"award-number":["2019 0295"]}],"id":[{"id":"10.13039\/501100003069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Ciencia y Tecnolog\u00eda","doi-asserted-by":"publisher","award":["CB-2014-01"],"award-info":[{"award-number":["CB-2014-01"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Ciencia y Tecnolog\u00eda","doi-asserted-by":"publisher","award":["241615"],"award-info":[{"award-number":["241615"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2021,3]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Infections caused by Trypanosoma brucei, Trypanosoma cruzi, Leishmania spp., Entamoeba\nhistolytica, Giardia lamblia, Plasmodium spp., and Trichomonas vaginalis, are part of a large\nlist of human parasitic diseases. Together, they cause more than 500 million infections per year.\nThese protozoa parasites affect both low- and high-income countries and their pharmacological\ntreatments are limited. Therefore, new and more effective drugs in preclinical development could\nimprove overall therapy for parasitic infections even when their mechanisms of action are unknown.\nIn this review, a number of heterocyclic compounds (diamidine, guanidine, quinoline, benzimidazole,\nthiazole, diazanaphthalene, and their derivatives) reported as antiprotozoal agents are discussed\nas options for developing new pharmacological treatments for parasitic diseases.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0929867327666200303170000","type":"journal-article","created":{"date-parts":[[2020,3,3]],"date-time":"2020-03-03T08:25:50Z","timestamp":1583223950000},"page":"583-606","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Recent Advances in the Development of Broad-Spectrum Antiprotozoal Agents"],"prefix":"10.2174","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7541-1267","authenticated-orcid":true,"given":"Antonio","family":"Moreno-Herrera","sequence":"first","affiliation":[{"name":"Laboratorio de Biotecnologia Farmaceutica, Centro de Biotecnologia Genomica, Instituto Politecnico Nacional, Reynosa 88710,Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8252-1835","authenticated-orcid":true,"given":"Sandra","family":"Cortez-Maya","sequence":"additional","affiliation":[{"name":"Instituto de Quimica, Universidad Nacional Autonoma de Mexico, Cd. Universitaria, Circuito Exterior, Coyoacan, Ciudad de Mexico 04510,Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0728-2018","authenticated-orcid":true,"given":"Virgilio","family":"Bocanegra-Garcia","sequence":"additional","affiliation":[{"name":"Laboratorio de Biotecnologia Farmaceutica, Centro de Biotecnologia Genomica, Instituto Politecnico Nacional, Reynosa 88710,Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7873-9062","authenticated-orcid":true,"given":"Bimal Krishna","family":"Banik","sequence":"additional","affiliation":[{"name":"Department of Mathematics and Natural Sciences, College of Sciences and Human Studies, Deanship of Research, Prince Mohammad Bin Fahd University, Al Khobar,Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9842-4167","authenticated-orcid":true,"given":"Gildardo","family":"Rivera","sequence":"additional","affiliation":[{"name":"Laboratorio de Biotecnologia Farmaceutica, Centro de Biotecnologia Genomica, Instituto Politecnico Nacional, Reynosa 88710,Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"e00101","DOI":"10.1128\/IAI.00101-17","volume":"85","author":"Burgess S.L.","year":"2017","unstructured":"Burgess S.L.; Gilchrist C.A.; Lynn T.C.; Petri W.A.; Jr. Parasitic protozoa and interactions with the host intestinal microbiota. Infect Immun 2017,85(8),e00101-e00117","journal-title":"Infect Immun"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1098\/rstb.2016.0088","volume":"372","author":"Cable J.","year":"2017","unstructured":"Cable J.; Barber I.; Boag B.; Ellison A.R.; Morgan E.R.; Murray K.; Pascoe E.L.; Sait S.M.; Wilson A.J.; Booth M.; Global change, parasite transmission and disease control: lessons from ecology. Philos Trans R Soc Lond B Biol Sci 2017,372(1719),372","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"ref=3","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.DMIH2-0013-2015","volume":"4","author":"Theel E.S.","year":"2016","unstructured":"Theel E.S.; Pritt B.S.; Parasites. Microbiol Spectr 2016,4(4)","journal-title":"Microbiol Spectr"},{"key":"ref=4","year":"2020","unstructured":"Neglected tropical diseases World Health OrganizationAvailable at:  ext-link-type=\"uri\"\nxmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"http:\/\/www.who.int\/neglected_diseases\/diseases\/en\/\">http:\/\/www.who.int\/neglected_ diseases\/diseases\/en\/2020","journal-title":"Neglected tropical diseases"},{"key":"ref=5","year":"2015","unstructured":"Guidelines for the treatment of malaria 3rd ed World Health OrganizationAvailable at:  ext-link-type=\"uri\"\nxmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"https:\/\/www.who.int\/docs\/default-source\/documents\/publications\/gmp\/guide-lines-for-the-treatment-of-malaria-eng.pdf\">https:\/\/www.who.int\/docs\/default-source\/documents\/publications\/gmp\/guide-lines-for-the-treatment-of-malaria-eng.pdf  (Accessed: Jun 12 2018) 2015","journal-title":"Guidelines for the treatment of malaria 3rd ed"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1111\/febs.14107","volume":"284","author":"Matuschewski K.","year":"2017","unstructured":"Matuschewski K.; Vaccines against malaria-still a long way to go. FEBS J 2017,284(16),2560-2568","journal-title":"FEBS J"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1001\/jama.298.18.2171","volume":"298","author":"Bern C.","year":"2007","unstructured":"Bern C.; Montgomery S.P.; Herwaldt B.L.; Rassi A.; Marin-Neto J.A.; Dantas R.O.; Maguire J.H.; Acquatella H.; Morillo C.; Kirchhoff L.V.; Gilman R.H.; Reyes P.A.; Salvatella R.; Moore A.C.; Evaluation and treatment of chagas disease in the United States: a systematic review. JAMA 2007,298(18),2171-2181","journal-title":"JAMA"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1056\/nejmc1510996","volume":"373","author":"Bern C.","year":"2015","unstructured":"Bern C.; Chagas\u2019 Disease. N Engl J Med 2015,373(19),1882","journal-title":"N Engl J Med"},{"key":"ref=9","first-page":"1","volume":"62","author":"Ponte-Sucre A.","year":"2015","unstructured":"Ponte-Sucre A.; Propiedades qu\u00edmicas estructurales de compuestos que act\u00faan contra el Trypanosoma brucei (Revisi\u00f3n). VITAE 2015,62,1-9","journal-title":"VITAE"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"207","DOI":"10.7705\/biomedica.v26i1.1514","volume":"26","author":"Soto J.","year":"2006","unstructured":"Soto J.; Soto P.; Miltefosina oral para el tratamiento de la leishmaniasis. Biomedica 2006,26(Suppl. 1),207-217","journal-title":"Biomedica"},{"key":"ref=11","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.cd006085.pub2","volume":"2","author":"Gonzales M.L.","year":"2009","unstructured":"Gonzales M.L.; Dans L.F.; Martinez E.G.; Antiamoebic drugs for treating amoebic colitis. Cochrane Database Syst Rev 2009,2(2)","journal-title":"Cochrane Database Syst Rev"},{"key":"ref=12","first-page":"301","volume":"53","author":"Chac\u00edn-Bonilla L.","year":"2012","unstructured":"Chac\u00edn-Bonilla L.; Farmacoterapia actual de la amibiasis, avances en nuevas drogas y dise\u00f1o de una vacuna. Invest Clin 2012,53(3),301-314","journal-title":"Invest Clin"},{"key":"ref=13","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007787.pub2","volume":"12","author":"Granados C.E.","year":"2012","unstructured":"Granados C.E.; Reveiz L.; Uribe L.G.; Criollo C.P.; Drugs for treating giardiasis. Cochrane Database Syst Rev 2012,12(12)","journal-title":"Cochrane Database Syst Rev"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"134","DOI":"10.2174\/1574891X10666150914122118","volume":"10","author":"Escobedo A.A.","year":"2015","unstructured":"Escobedo A.A.; Almirall P.; Cimerman S.; Lalle M.; Pacheco F.; Acanda C.Z.; S\u00e1nchez N.; Chloroquine: an old drug with new perspective against giardiasis. Recent Pat Antiinfect Drug Discov 2015,10(2),134-141","journal-title":"Recent Pat Antiinfect Drug Discov"},{"key":"ref=15","first-page":"679","volume":"12","author":"Mahdi N.K.","year":"2006","unstructured":"Mahdi N.K.; Gany Z.H.; Sharief M.; Alternative drugs against Trichomonas vaginalis. East Mediterr Health J 2006,12(5),679-684","journal-title":"East Mediterr Health J"},{"key":"ref=16","author":"Sharma R.S.","unstructured":"Sharma R.S.; Mathur A.K.; Chandhiok N.; Datey S.; Saxena N.C.; Gopalan S.; Sharma S.; Mittal S.; Sehgal R.; Sumandal B.K.; Chanda A.; Salvi V.; Mutalik N.; Coyaji K.J.; Gibsson A.; Hazari K.; Kalgutkar S.;"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1007\/s00436-015-4340-3","volume":"114","author":"Vieira P.","year":"2015","unstructured":"Vieira P.; B.; Giordani, R.B.; Macedo, A.J.; Tasca, T. Natural and synthetic compound anti-Trichomonas vaginalis: an update review. Parasitol Res 2015,114(4),1249-1261","journal-title":"Parasitol Res"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1016\/S0140-6736(17)31510-6","volume":"390","author":"B\u00fcscher P.","year":"2017","unstructured":"B\u00fcscher P.; Cecchi G.; Jamonneau V.; Priotto G.; Human African trypanosomiasis. Lancet 2017,390(10110),2397-2409","journal-title":"Lancet"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"701","DOI":"10.2174\/0929867324666170120160034","volume":"24","author":"Cullen D.R.","year":"2017","unstructured":"Cullen D.R.; Mocerino M.; A brief review of drug discovery research for human African trypanosomiasis. Curr Med Chem 2017,24(7),701-717","journal-title":"Curr Med Chem"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/S0140-6736(17)31612-4","volume":"391","author":"P\u00e9rez-Molina J.A.","year":"2018","unstructured":"P\u00e9rez-Molina J.A.; Molina I.; Chagas disease. Lancet 2018,391(10115),82-94","journal-title":"Lancet"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"750","DOI":"10.12688\/f1000research.11120.1","volume":"6","author":"Torres-Guerrero E.","year":"2017","unstructured":"Torres-Guerrero E.; Quintanilla-Cedillo M.R.; Ruiz-Esmenjaud J.; Arenas R.; Leishmaniasis: a review. F1000 Res 2017,6,750","journal-title":"F1000 Res"},{"key":"ref=22","author":"Prakash V.","year":"2017","unstructured":"Prakash V.; Bhimji S.; Abscess, Amebic Liver. StatPearls. Available at:  ext-link-type=\"uri\"\nxmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK430832\/\">https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK430832\/2017"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"2790","DOI":"10.1017\/S0950268815003040","volume":"144","author":"Adam E.A.","year":"2016","unstructured":"Adam E.A.; Yoder J.S.; Gould L.H.; Hlavsa M.C.; Gargano J.W.; Giardiasis outbreaks in the United States, 1971-2011. Epidemiol Infect 2016,144(13),2790-2801","journal-title":"Epidemiol Infect"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.biotechadv.2013.10.009","volume":"32","author":"Koehler A.V.","year":"2014","unstructured":"Koehler A.V.; Jex A.R.; Haydon S.R.; Stevens M.A.; Gasser R.B.; Giardia\/giardiasis - a perspective on diagnostic and analytical tools. Biotechnol Adv 2014,32(2),280-289","journal-title":"Biotechnol Adv"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"17050","DOI":"10.1038\/nrdp.2017.50","volume":"3","author":"Phillips M.A.","year":"2017","unstructured":"Phillips M.A.; Burrows J.N.; Manyando C.; van Huijsduijnen R.H.; Van Voorhis W.C.; Wells T.N.C.; Malaria. Nat Rev Dis Primers 2017,3,17050","journal-title":"Nat Rev Dis Primers"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"404","DOI":"10.15698\/mic2016.09.526","volume":"3","author":"Menezes C.B.","year":"2016","unstructured":"Menezes C.B.; Frasson A.P.; Tasca T.; Trichomoniasis - are we giving the deserved attention to the most common non-viral sexually transmitted disease worldwide? Microb Cell 2016,3(9),404-419","journal-title":"Microb Cell"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.2174\/1568026616666160930150429","volume":"17","author":"de Brum Vieira P.","year":"2017","unstructured":"de Brum Vieira P.; Tasca T.; Secor W.E.; Challenges and persistent questions in the treatment of trichomoniasis. Curr Top Med Chem 2017,17(11),1249-1265","journal-title":"Curr Top Med Chem"},{"key":"ref=28","unstructured":"Leverage diverse datasets to facilitate drug discovery for neglected disease pathgens The TDR Targets DatabaseAvailable at:  ext-link-type=\"uri\"\nxmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"http:\/\/tdrtargets.org\">http:\/\/tdrtargets.org","journal-title":"Leverage diverse datasets to facilitate drug discovery for neglected disease pathgens"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1021\/jm990071c","volume":"42","author":"Francesconi I.","year":"1999","unstructured":"Francesconi I.; Wilson W.D.; Tanious F.A.; Hall J.E.; Bender B.C.; Tidwell R.R.; McCurdy D.; Boykin D.W.; 2,4-Diphenyl furan diamidines as novel anti-Pneumocystis carinii pneumonia agents. J Med Chem 1999,42(12),2260-2265","journal-title":"J Med Chem"},{"key":"ref=30","first-page":"47","volume":"14","author":"Bailly C.","year":"1999","unstructured":"Bailly C.; Dassonneville L.; Carrasco C.; Lucas D.; Kumar A.; Boykin D.W.; Wilson W.D.; Relationships between topoisomerase II inhibition, sequence-specificity and DNA binding mode of dicationic diphenylfuran derivatives. Anticancer Drug Des 1999,14(1),47-60","journal-title":"Anticancer Drug Des"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1517\/13543776.15.9.1241","volume":"15","author":"Dardonville C.","year":"2005","unstructured":"Dardonville C.; Recent advances in antitrypanosomal chemotherapy: patent literature 2002-2005. Expert Opin Ther Pat 2005,15,1241-1257","journal-title":"Expert Opin Ther Pat"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/S0140-6736(09)60829-1","volume":"375","author":"Brun R.","year":"2010","unstructured":"Brun R.; Blum J.; Chappuis F.; Burri C.; Human African trypanosomiasis. Lancet 2010,375(9709),148-159","journal-title":"Lancet"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"4185","DOI":"10.1128\/AAC.00225-09","volume":"53","author":"Wenzler T.","year":"2009","unstructured":"Wenzler T.; Boykin D.W.; Ismail M.A.; Hall J.E.; Tidwell R.R.; Brun R.; New treatment option for second-stage African sleeping sickness: in vitro and in vivo efficacy of aza analogs of DB289. Antimicrob Agents Chemother 2009,53(10),4185-4192","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=34","first-page":"876","volume":"11","author":"Paine M.F.","year":"2010","unstructured":"Paine M.F.; Wang M.Z.; Generaux C.N.; Boykin D.W.; Wilson W.D.; De Koning H.P.; Olson C.A.; Pohlig G.; Burri C.; Brun R.; Murilla G.A.; Thuita J.K.; Barrett M.P.; Tidwell R.R.; Diamidines for human African trypanosomiasis. Curr Opin Investig Drugs 2010,11(8),876-883","journal-title":"Curr Opin Investig Drugs"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/0223-5234(96)83970-5","volume":"31","author":"Kumar A.","year":"1996","unstructured":"Kumar A.; Boykin D.; Wilson W.; Jones S.; Bender B.; Dykstra C.; Hall J.; Tidwell R.; Anti-Pneumocystis carinii pneumonia activity of dicationic 2,4-diarylpyrimidines. Eur J Med Chem 1996,31(10),767-773","journal-title":"Eur J Med Chem"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/S0223-5234(97)89640-7","volume":"32","author":"Boykin D.","year":"1998","unstructured":"Boykin D.; Kumar A.; Bajic M.; Wilson W.; Bender B.; Hall J.; Tidwell R.; Anti-Pneumocystis carinii pneumonia activity of dicationic diaryl methylprimidines. Eur J Med Chem 1998,32(12),965-972","journal-title":"Eur J Med Chem"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"3551","DOI":"10.1016\/j.bmc.2010.03.058","volume":"18","author":"Branowska D.","year":"2010","unstructured":"Branowska D.; Farahat A.A.; Kumar A.; Wenzler T.; Brun R.; Liu Y.; Wilson W.D.; Boykin D.W.; Synthesis and antiprotozoal activity of 2,5-bis[amidinoaryl]thiazoles. Bioorg Med Chem 2010,18(10),3551-3558","journal-title":"Bioorg Med Chem"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/j.bmc.2010.11.047","volume":"19","author":"Ismail M.A.","year":"2011","unstructured":"Ismail M.A.; Bialy S.A.; Brun R.; Wenzler T.; Nanjunda R.; Wilson W.D.; Boykin D.W.; Dicationic phenyl-2,2\u2032-bichalcophenes and analogues as antiprotozoal agents. Bioorg Med Chem 2011,19(2),978-984","journal-title":"Bioorg Med Chem"},{"key":"ref=39","first-page":"39","author":"Nguyen N.","year":"2007","unstructured":"Nguyen N.; Boykin D.W.; Wilson W.D.;  DNA minor groove interactions of antiparasitic diamidines: reevaluation of the crescent-shape concept in groove-binding 2007,39-66","journal-title":"DNA minor groove interactions of antiparasitic diamidines: reevaluation of the crescent-shape concept in groove-binding"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.bmc.2007.10.042","volume":"16","author":"Ismail M.A.","year":"2008","unstructured":"Ismail M.A.; Arafa R.K.; Wenzler T.; Brun R.; Tanious F.A.; Wilson W.D.; Boykin D.W.; Synthesis and antiprotozoal activity of novel bis-benzamidino imidazo[1,2-a]pyridines and 5,6,7,8-tetrahydro-imidazo[1,2-a]pyridines. Bioorg Med Chem 2008,16(2),683-691","journal-title":"Bioorg Med Chem"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"6651","DOI":"10.1016\/j.bmc.2009.07.080","volume":"17","author":"Hu L.","year":"2009","unstructured":"Hu L.; Arafa R.K.; Ismail M.A.; Patel A.; Munde M.; Wilson W.D.; Wenzler T.; Brun R.; Boykin D.W.; Synthesis and activity of azaterphenyl diamidines against Trypanosoma brucei rhodesiense and Plasmodium falciparum. Bioorg Med Chem 2009,17(18),6651-6658","journal-title":"Bioorg Med Chem"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"6732","DOI":"10.1016\/j.bmc.2013.08.006","volume":"21","author":"Hu L.","year":"2013","unstructured":"Hu L.; Patel A.; Bondada L.; Yang S.; Wang M.Z.; Munde M.; Wilson W.D.; Wenzler T.; Brun R.; Boykin D.W.; Synthesis and antiprotozoal activity of dicationic 2,6-diphenylpyrazines and aza-analogues. Bioorg Med Chem 2013,21(21),6732-6741","journal-title":"Bioorg Med Chem"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.biopha.2010.10.006","volume":"65","author":"Giordani R.B.","year":"2011","unstructured":"Giordani R.B.; Ara\u00fajo D.P.; Duarte M.; Zuanazzi J.A.; Tasca T.; De Almeida M.V.; Anti-protozoal activity of diamine derivatives. Biomed Pharmacother 2011,65(1),60-62","journal-title":"Biomed Pharmacother"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1021\/jm7013088","volume":"51","author":"Rodr\u00edguez F.","year":"2008","unstructured":"Rodr\u00edguez F.; Rozas I.; Kaiser M.; Brun R.; Nguyen B.; Wilson W.D.; Garc\u00eda R.N.; Dardonville C.; New bis(2-aminoimidazoline) and bisguanidine DNA minor groove binders with potent in vivo antitrypanosomal and antiplasmodial activity. J Med Chem 2008,51(4),909-923","journal-title":"J Med Chem"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"3748","DOI":"10.1021\/jm060295c","volume":"49","author":"Dardonville C.","year":"2006","unstructured":"Dardonville C.; Barrett M.P.; Brun R.; Kaiser M.; Tanious F.; Wilson W.D.; DNA binding affinity of bisguanidine and bis(2-aminoimidazoline) derivatives with in vivo antitrypanosomal activity. J Med Chem 2006,49(12),3748-3752","journal-title":"J Med Chem"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1021\/jm031024u","volume":"47","author":"Dardonville C.","year":"2004","unstructured":"Dardonville C.; Brun R.; Bisguanidine, bis(2-amino-imidazoline), and polyamine derivatives as potent and selective chemotherapeutic agents against Trypanosoma brucei rhodesiense. Synthesis and in vitro evaluation. J Med Chem 2004,47(9),2296-2307","journal-title":"J Med Chem"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"5480","DOI":"10.1021\/jm058190h","volume":"48","author":"Arafa R.K.","year":"2005","unstructured":"Arafa R.K.; Brun R.; Wenzler T.; Tanious F.A.; Wilson W.D.; Stephens C.E.; Boykin D.W.; Synthesis, DNA affinity, and antiprotozoal activity of fused ring dicationic compounds and their prodrugs. J Med Chem 2005,48(17),5480-5488","journal-title":"J Med Chem"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.ejmech.2014.04.083","volume":"81","author":"R\u00edos Mart\u00ednez C.H.","year":"2014","unstructured":"R\u00edos Mart\u00ednez C.H.; Lagartera L.; Kaiser M.; Dardonville C.; Antiprotozoal activity and DNA binding of N-substituted N-phenylbenzamide and 1,3-diphenylurea bisguanidines. Eur J Med Chem 2014,81,481-491","journal-title":"Eur J Med Chem"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1016\/S0960-894X(03)00319-6","volume":"13","author":"Stephens C.E.","year":"2003","unstructured":"Stephens C.E.; Brun R.; Salem M.M.; Werbovetz K.A.; Tanious F.; Wilson W.D.; Boykin D.W.; The activity of diguanidino and \u2018reversed\u2019 diamidino 2,5-diarylfurans versus Trypanosoma cruzi and Leishmania donovani. Bioorg Med Chem Lett 2003,13(12),2065-2069","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1515\/HC.2004.10.6.423","volume":"10","author":"Arafa R.K.","year":"2004","unstructured":"Arafa R.K.; Brun R.; Werbovetz K.A.; Tanious F.A.; David Wilson W.; Boykin D.W.; Synthesis of dicationic 2,5-diarylpyrroles. Heterocycl Commun 2004,10,423-428","journal-title":"Heterocycl Commun"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"2901","DOI":"10.1016\/j.ejmech.2008.02.008","volume":"43","author":"Arafa R.K.","year":"2008","unstructured":"Arafa R.K.; Ismail M.A.; Munde M.; Wilson W.D.; Wenzler T.; Brun R.; Boykin D.W.; Novel linear triaryl guanidines, N-substituted guanidines and potential prodrugs as antiprotozoal agents. Eur J Med Chem 2008,43(12),2901-2908","journal-title":"Eur J Med Chem"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"5473","DOI":"10.1021\/jm400508e","volume":"56","author":"Patrick D.A.","year":"2013","unstructured":"Patrick D.A.; Ismail M.A.; Arafa R.K.; Wenzler T.; Zhu X.; Pandharkar T.; Jones S.K.; Werbovetz K.A.; Brun R.; Boykin D.W.; Tidwell R.R.; Synthesis and antiprotozoal activity of dicationic m-terphenyl and 1,3-dipyridylbenzene derivatives. J Med Chem 2013,56(13),5473-5494","journal-title":"J Med Chem"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"5852","DOI":"10.1016\/j.ejmech.2011.09.047","volume":"46","author":"Arafa R.K.","year":"2011","unstructured":"Arafa R.K.; Wenzler T.; Brun R.; Chai Y.; Wilson W.D.; Molecular modeling study and synthesis of novel dicationic flexible triaryl guanidines and imidamides as antiprotozoal agents. Eur J Med Chem 2011,46(12),5852-5860","journal-title":"Eur J Med Chem"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.bmc.2008.11.009","volume":"17","author":"Ekoue-Kovi K.","year":"2009","unstructured":"Ekoue-Kovi K.; Yearick K.; Iwaniuk D.P.; Natarajan J.K.; Alumasa J.; de Dios A.C.; Roepe P.D.; Wolf C.; Synthesis and antimalarial activity of new 4-amino-7-chloroquinolyl amides, sulfonamides, ureas and thioureas. Bioorg Med Chem 2009,17(1),270-283","journal-title":"Bioorg Med Chem"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"6530","DOI":"10.1016\/j.bmcl.2008.10.049","volume":"18","author":"Kumar A.","year":"2008","unstructured":"Kumar A.; Srivastava K.; Raja Kumar S.; Puri S.K.; Chauhan P.M.S.; Synthesis and bioevaluation of hybrid 4-aminoquinoline triazines as a new class of antimalarial agents. Bioorg Med Chem Lett 2008,18(24),6530-6533","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"6398","DOI":"10.1016\/j.bmc.2010.07.008","volume":"18","author":"Nava-Zuazo C.","year":"2010","unstructured":"Nava-Zuazo C.; Estrada-Soto S.; Guerrero-Alvarez J.; Le\u00f3n-Rivera I.; Molina-Salinas G.M.; Said-Fern\u00e1ndez S.; Chan-Bacab M.J.; Cedillo-Rivera R.; Moo-Puc R.; Mir\u00f3n-L\u00f3pez G.; Navarrete-Vazquez G.; Design, synthesis, and in vitro antiprotozoal, antimycobacterial activities of N-2-[(7-chloroquinolin-4-yl)amino]ethylureas. Bioorg Med Chem 2010,18(17),6398-6403","journal-title":"Bioorg Med Chem"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.2174\/1568026023392986","volume":"2","author":"Dom\u00ednguez J.N.","year":"2002","unstructured":"Dom\u00ednguez J.N.; Chemotherapeutic agents against malaria: what next after chloroquine? Curr Top Med Chem 2002,2(11),1173-1185","journal-title":"Curr Top Med Chem"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1016\/j.bmc.2009.01.013","volume":"17","author":"de Souza M.V.","year":"2009","unstructured":"de Souza M.V.; Pais K.C.; Kaiser C.R.; Peralta M.A.; de L Ferreira, M.; Louren\u00e7o, M.C. Synthesis and in vitro antitubercular activity of a series of quinoline derivatives. Bioorg Med Chem 2009,17(4),1474-1480","journal-title":"Bioorg Med Chem"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"6272","DOI":"10.1016\/j.bmcl.2009.09.098","volume":"19","author":"Cand\u00e9a A.L.","year":"2009","unstructured":"Cand\u00e9a A.L.; Ferreira, Mde.L.; Pais, K.C.; Cardoso, L.N.; Kaiser, C.R.; Henriques, Md.; Louren\u00e7o, M.C.; Bezerra, F.A.; de Souza, M.V. Synthesis and antitubercular activity of 7-chloro-4-quinolinylhydrazones derivatives. Bioorg Med Chem Lett 2009,19(22),6272-6274","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.ejmech.2008.08.011","volume":"44","author":"Vale N.","year":"2009","unstructured":"Vale N.; Moreira R.; Gomes P.; Primaquine revisited six decades after its discovery. Eur J Med Chem 2009,44(3),937-953","journal-title":"Eur J Med Chem"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"402","DOI":"10.4269\/ajtmh.2006.75.402","volume":"75","author":"Hill D.R.","year":"2006","unstructured":"Hill D.R.; Baird J.K.; Parise M.E.; Lewis L.S.; Ryan E.T.; Magill A.J.; Primaquine: report from CDC expert meeting on malaria chemoprophylaxis I. Am J Trop Med Hyg 2006,75(3),402-415","journal-title":"Am J Trop Med Hyg"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S0940-2993(99)80010-4","volume":"51","author":"Constantino L.","year":"1999","unstructured":"Constantino L.; Paix\u00e3o P.; Moreira R.; Portela M.J.; Do Rosario V.E.; Iley J.; Metabolism of primaquine by liver homogenate fractions. Evidence for monoamine oxidase and cytochrome P450 involvement in the oxidative deamination of primaquine to carboxyprimaquine. Exp Toxicol Pathol 1999,51(4-5),299-303","journal-title":"Exp Toxicol Pathol"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/j.bmc.2006.10.036","volume":"15","author":"Kaur K.","year":"2007","unstructured":"Kaur K.; Patel S.R.; Patil P.; Jain M.; Khan S.I.; Jacob M.R.; Tekwani B.L.; Jain R.; Synthesis, antimalarial, antileishmanial, antimicrobial, cytotoxicity, and methemoglobin (MetHB) formation activities of new 8-quinolinamines. Bioorg Med Chem 2007,15(2),915-930","journal-title":"Bioorg Med Chem"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.bmc.2010.11.036","volume":"19","author":"Kaur K.","year":"2011","unstructured":"Kaur K.; Jain M.; Khan S.I.; Jacob M.R.; Tekwani B.L.; Singh S.; Singh P.P.; Jain R.; Synthesis, antiprotozoal, antimicrobial, \u03b2-hematin inhibition, cytotoxicity and methemoglobin (MetHb) formation activities of bis(8-amino-quinolines). Bioorg Med Chem 2011,19(1),197-210","journal-title":"Bioorg Med Chem"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1016\/j.bmcl.2009.02.013","volume":"19","author":"Ara\u00fajo N.C.","year":"2009","unstructured":"Ara\u00fajo N.C.; Barton V.; Jones M.; Stocks P.A.; Ward S.A.; Davies J.; Bray P.G.; Shone A.E.; Cristiano M.L.; O\u2019Neill P.M.; Semi-synthetic and synthetic 1,2,4-trioxaquines and 1,2,4-trioxolaquines: synthesis, preliminary SAR and comparison with acridine endoperoxide conjugates. Bioorg Med Chem Lett 2009,19(7),2038-2043","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"3080","DOI":"10.1016\/j.bmc.2013.03.052","volume":"21","author":"Salahuddin A.","year":"2013","unstructured":"Salahuddin A.; Inam A.; van Zyl R.L.; Heslop D.C.; Chen C.T.; Avecilla F.; Agarwal S.M.; Azam A.; Synthesis and evaluation of 7-chloro-4-(piperazin-1-yl)quinoline-sulfonamide as hybrid antiprotozoal agents. Bioorg Med Chem 2013,21(11),3080-3089","journal-title":"Bioorg Med Chem"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1128\/AAC.39.8.1756","volume":"39","author":"Hong Y.L.","year":"1995","unstructured":"Hong Y.L.; Hossler P.A.; Calhoun D.H.; Meshnick S.R.; Inhibition of recombinant Pneumocystis carinii dihydropteroate synthetase by sulfa drugs. Antimicrob Agents Chemother 1995,39(8),1756-1763","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"63","DOI":"10.2174\/1386207053328101","volume":"8","author":"Tekwani B.L.","year":"2005","unstructured":"Tekwani B.L.; Walker L.A.; Targeting the hemozoin synthesis pathway for new antimalarial drug discovery: technologies for in vitro beta-hematin formation assay. Comb Chem High Throughput Screen 2005,8(1),63-79","journal-title":"Comb Chem High Throughput Screen"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.bmcl.2016.12.043","volume":"27","author":"Ansari M.F.","year":"2017","unstructured":"Ansari M.F.; Hayat F.; Inam A.; Kathrada F.; van Zyl R.L.; Coetzee M.; Ahmad K.; Shin D.; Azam A.; New antiprotozoal agents: synthesis and biological evaluation of different 4-(7-chloroquinolin-4-yl) piperazin-1-yl) pyrrolidin-2-yl)methanone derivatives. Bioorg Med Chem Lett 2017,27(3),460-465","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"48368","DOI":"10.1039\/C5RA05472A","volume":"5","author":"Inam A.","year":"2015","unstructured":"Inam A.; Van Zyl R.L.; van Vuuren N.J.; Chen C.T.; Avecilla F.; Agarwal S.M.; Azam A.; Chloroquinoline-acetamide hybrids: a promising series of potential antiprotozoal agents. RSC Advances 2015,5(60),48368-48381","journal-title":"RSC Advances"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.ejmech.2015.05.013","volume":"98","author":"Leeza Zaidi","year":"2015","unstructured":"Leeza Zaidi ; S.; Mittal, S.; Rajala, M.S.; Avecilla, F.; Husain, M.; Azam, A. Synthesis, characterization and antiamoebic activity of chalcones bearing N-substituted ethanamine tail. Eur J Med Chem 2015,98,179-189","journal-title":"Eur J Med Chem"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"3950","DOI":"10.1016\/j.bmcl.2016.07.006","volume":"26","author":"Zhao Y.","year":"2016","unstructured":"Zhao Y.; Shadrick W.R.; Wallace M.J.; Wu Y.; Griffith E.C.; Qi J.; Yun M.K.; White S.W.; Lee R.E.; Pterin-sulfa conjugates as dihydropteroate synthase inhibitors and antibacterial agents. Bioorg Med Chem Lett 2016,26(16),3950-3954","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"2750","DOI":"10.1016\/j.bmcl.2013.02.054","volume":"23","author":"Upadhayaya R.S.","year":"2013","unstructured":"Upadhayaya R.S.; Dixit S.S.; F\u00f6ldesi A.; Chattopadhyaya J.; New antiprotozoal agents: their synthesis and biological evaluations. Bioorg Med Chem Lett 2013,23(9),2750-2758","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1128\/AAC.49.4.1521-1528.2005","volume":"49","author":"Garcia S.","year":"2005","unstructured":"Garcia S.; Ramos C.O.; Senra J.F.; Vilas-Boas F.; Rodrigues M.M.; Campos-de-Carvalho A.C.; Ribeiro-Dos-Santos R.; Soares M.B.; Treatment with benznidazole during the chronic phase of experimental Chagas\u2019 disease decreases cardiac alterations. Antimicrob Agents Chemother 2005,49(4),1521-1528","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"43","DOI":"10.2174\/1568006023337745","volume":"2","author":"Rivarola H.W.","year":"2002","unstructured":"Rivarola H.W.; Paglini-Oliva P.A.; Trypanosoma cruzi trypanothione reductase inhibitors: phenothiazines and related compounds modify experimental Chagas\u2019 disease evolution. Curr Drug Targets Cardiovasc Haematol Disord 2002,2(1),43-52","journal-title":"Curr Drug Targets Cardiovasc Haematol Disord"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.bbrc.2010.07.099","volume":"399","author":"Paila Y.D.","year":"2010","unstructured":"Paila Y.D.; Saha B.; Chattopadhyay A.; Amphotericin B inhibits entry of Leishmania donovani into primary macrophages. Biochem Biophys Res Commun 2010,399(3),429-433","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.1128\/AAC.01508-05","volume":"50","author":"Gros L.","year":"2006","unstructured":"Gros L.; Castillo-Acosta V.M.; Jim\u00e9nez Jim\u00e9nez C.; Sealey-Cardona M.; Vargas S.; Manuel Est\u00e9vez A.; Yardley V.; Rattray L.; Croft S.L.; Ruiz-Perez L.M.; Urbina J.A.; Gilbert I.H.; Gonz\u00e1lez-Pacanowska D.; New azasterols against Trypanosoma brucei: role of 24-sterol methyltransferase in inhibitor action. Antimicrob Agents Chemother 2006,50(8),2595-2601","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1021\/cr020033s","volume":"103","author":"Horton D.A.","year":"2003","unstructured":"Horton D.A.; Bourne G.T.; Smythe M.L.; The combinatorial synthesis of bicyclic privileged structures or privileged substructures. Chem Rev 2003,103(3),893-930","journal-title":"Chem Rev"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ejmech.2005.09.001","volume":"41","author":"Navarrete-V\u00e1zquez G.","year":"2006","unstructured":"Navarrete-V\u00e1zquez G.; Rojano-Vilchis, Mde.M.; Y\u00e9pez-Mulia, L.; Mel\u00e9ndez, V.; Gerena, L.; Hern\u00e1ndez-Campos, A.; Castillo, R.; Hern\u00e1ndez-Luis, F. Synthesis and antiprotozoal activity of some 2-(trifluoromethyl)-1H-benzimida-zole bioisosteres. Eur J Med Chem 2006,41(1),135-141","journal-title":"Eur J Med Chem"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"3147","DOI":"10.1016\/j.bmcl.2008.05.009","volume":"18","author":"Torres-G\u00f3mez H.","year":"2008","unstructured":"Torres-G\u00f3mez H.; Hern\u00e1ndez-N\u00fa\u00f1ez E.; Le\u00f3n-Rivera I.; Guerrero-Alvarez J.; Cedillo-Rivera R.; Moo-Puc R.; Argotte-Ramos R.; Rodr\u00edguez-Guti\u00e9rrez, Mdel.C.; Chan-Bacab, M.J.; Navarrete-V\u00e1zquez, G. Design, synthesis and in vitro antiprotozoal activity of benzimidazole-pentamidine hybrids. Bioorg Med Chem Lett 2008,18(11),3147-3151","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1016\/S0960-894X(02)00346-3","volume":"12","author":"Valdez J.","year":"2002","unstructured":"Valdez J.; Cedillo R.; Hern\u00e1ndez-Campos A.; Y\u00e9pez L.; Hern\u00e1ndez-Luis F.; Navarrete-V\u00e1zquez G.; Tapia A.; Cort\u00e9s R.; Hern\u00e1ndez M.; Castillo R.; Synthesis and antiparasitic activity of 1H-benzimidazole derivatives. Bioorg Med Chem Lett 2002,12(16),2221-2224","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1016\/j.bmc.2008.12.059","volume":"17","author":"Valdez-Padilla D.","year":"2009","unstructured":"Valdez-Padilla D.; Rodr\u00edguez-Morales S.; Hern\u00e1ndez-Campos A.; Hern\u00e1ndez-Luis F.; Y\u00e9pez-Mulia L.; Tapia-Contreras A.; Castillo R.; Synthesis and antiprotozoal activity of novel 1-methylbenzimidazole derivatives. Bioorg Med Chem 2009,17(4),1724-1730","journal-title":"Bioorg Med Chem"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ejmech.2012.03.014","volume":"52","author":"Hern\u00e1ndez-Covarrubias C.","year":"2012","unstructured":"Hern\u00e1ndez-Covarrubias C.; Vilchis-Reyes M.A.; Y\u00e9pez-Mulia L.; S\u00e1nchez-D\u00edaz R.; Navarrete-V\u00e1zquez G.; Hern\u00e1ndez-Campos A.; Castillo R.; Hern\u00e1ndez-Luis F.; Exploring the interplay of physicochemical properties, membrane permeability and giardicidal activity of some benzimidazole derivatives. Eur J Med Chem 2012,52,193-204","journal-title":"Eur J Med Chem"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"3135","DOI":"10.1016\/j.ejmech.2010.03.050","volume":"45","author":"Hern\u00e1ndez-Luis F.","year":"2010","unstructured":"Hern\u00e1ndez-Luis F.; Hern\u00e1ndez-Campos A.; Castillo R.; Navarrete-V\u00e1zquez G.; Soria-Arteche O.; Hern\u00e1ndez-Hern\u00e1ndez M.; Y\u00e9pez-Mulia L.; Synthesis and biological activity of 2-(trifluoromethyl)-1H-benzimidazole derivatives against some protozoa and Trichinella spiralis. Eur J Med Chem 2010,45(7),3135-3141","journal-title":"Eur J Med Chem"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"6838","DOI":"10.1016\/j.bmcl.2013.10.011","volume":"23","author":"Soria-Arteche O.","year":"2013","unstructured":"Soria-Arteche O.; Hern\u00e1ndez-Campos A.; Y\u00e9pez-Mulia L.; Trejo-Soto P.J.; Hern\u00e1ndez-Luis F.; Gres-Molina J.; Maldonado L.A.; Castillo R.; Synthesis and antiprotozoal activity of nitazoxanide-N-methylbenzimidazole hybrids. Bioorg Med Chem Lett 2013,23(24),6838-6841","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"4038","DOI":"10.1016\/j.bmc.2016.06.047","volume":"24","author":"Karaaslan C.","year":"2016","unstructured":"Karaaslan C.; Kaiser M.; Brun R.; G\u00f6ker H.; Synthesis and potent antiprotozoal activity of mono\/di amidino 2-anilinobenzimidazoles versus Plasmodium falciparum and Trypanosoma brucei rhodesiense. Bioorg Med Chem 2016,24(18),4038-4044","journal-title":"Bioorg Med Chem"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"6718","DOI":"10.1016\/j.bmc.2005.07.024","volume":"13","author":"Ismail M.A.","year":"2005","unstructured":"Ismail M.A.; Batista-Parra A.; Miao Y.; Wilson W.D.; Wenzler T.; Brun R.; Boykin D.W.; Dicationic near-linear biphenyl benzimidazole derivatives as DNA-targeted antiprotozoal agents. Bioorg Med Chem 2005,13(24),6718-6726","journal-title":"Bioorg Med Chem"},{"key":"ref=88","first-page":"136","volume":"1","author":"Siddiqui N.","year":"2009","unstructured":"Siddiqui N.; Arshad M.F.; Ahsan W.; Alam M.S.; Thiazoles: a valuable insight into the recent advances and biological activities. Int J Pharm Sci Drug Res 2009,1(3),136-143","journal-title":"Int J Pharm Sci Drug Res"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"6819","DOI":"10.1021\/jm060727j","volume":"49","author":"Das J.","year":"2006","unstructured":"Das J.; Chen P.; Norris D.; Padmanabha R.; Lin J.; Moquin R.V.; Shen Z.; Cook L.S.; Doweyko A.M.; Pitt S.; Pang S.; Shen D.R.; Fang Q.; de Fex H.F.; McIntyre K.W.; Shuster D.J.; Gillooly K.M.; Behnia K.; Schieven G.L.; Wityak J.; Barrish J.C.; 2-aminothiazole as a novel kinase inhibitor template. Structure-activity relationship studies toward the discovery of N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1- piperazinyl)]-2-methyl-4-pyrimidinyl]amino)]-1,3-thiazole-5-carboxamide (dasatinib, BMS-354825) as a potent pan-Src kinase inhibitor. J Med Chem 2006,49(23),6819-6832","journal-title":"J Med Chem"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1590\/S0100-40422003000300014","volume":"26","author":"De Souza M.V.N.","year":"2003","unstructured":"De Souza M.V.N.; De Almeida M.V.; Drogas anti-VIH: pasado, presente e perspectivas futuras. Quim Nova 2003,26,366-372","journal-title":"Quim Nova"},{"key":"ref=91","first-page":"165","volume":"11","author":"Pasqualotto A.C.","year":"2010","unstructured":"Pasqualotto A.C.; Thiele K.O.; Goldani L.Z.; Novel triazole antifungal drugs: focus on isavuconazole, ravuconazole and albaconazole. Curr Opin Investig Drugs 2010,11(2),165-174","journal-title":"Curr Opin Investig Drugs"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1086\/428839","volume":"40","author":"Fox L.M.","year":"2005","unstructured":"Fox L.M.; Saravolatz L.D.; Nitazoxanide: a new thiazolide antiparasitic agent. Clin Infect Dis 2005,40(8),1173-1180","journal-title":"Clin Infect Dis"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.5012\/bkcs.2005.26.11.1771","volume":"26","author":"Rehman M.Z.","year":"2005","unstructured":"Rehman M.Z.; Anwar C.J.; Ahmad S.; An efficient synthesis of 2-Alkyl-4-hydroxy-2H-1,2-benzothiazine-3-carbo-xamide-1,1-dioxides. Bull Korean Chem Soc 2005,26,1771-1775","journal-title":"Bull Korean Chem Soc"},{"key":"ref=94","first-page":"175","volume":"14","author":"Knadler M.P.","year":"1986","unstructured":"Knadler M.P.; Bergstrom R.F.; Callaghan J.T.; Rubin A.; Nizatidine, an H2-blocker. Its metabolism and disposition in man. Drug Metab Dispos 1986,14(2),175-182","journal-title":"Drug Metab Dispos"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0048-3575(03)00065-8","volume":"76","author":"Nauen R.","year":"2003","unstructured":"Nauen R.; Ebbinghaus-Kintscher U.; Salgado V.L.; Kaussmann M.; Thiamethoxam is a neonicotinoid precursor converted to clothianidin in insects and plants. Pestic Biochem Physiol 2003,76(2),55-69","journal-title":"Pestic Biochem Physiol"},{"key":"ref=96","first-page":"28216","volume":"83","author":"Rossignol J.F.","year":"1975","unstructured":"Rossignol J.F.; Cavier R.; A new derivative of 2-benzamido 5-nitrothiazoles. Chem Abstr 1975,83,28216","journal-title":"Chem Abstr"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"387","DOI":"10.5414\/CPP38387","volume":"38","author":"Broekhuysen J.","year":"2000","unstructured":"Broekhuysen J.; Stockis A.; Lins R.L.; De Graeve J.; Rossignol J.F.; Nitazoxanide: pharmacokinetics and metabolism in man. Int J Clin Pharmacol Ther 2000,38(8),387-394","journal-title":"Int J Clin Pharmacol Ther"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"3168","DOI":"10.1016\/j.bmcl.2011.02.100","volume":"21","author":"Navarrete-Vazquez G.","year":"2011","unstructured":"Navarrete-Vazquez G.; Ch\u00e1vez-Silva F.; Argotte-Ramos R.; Rodr\u00edguez-Guti\u00e9rrez, Mdel.C.; Chan-Bacab, M.J.; Cedillo-Rivera, R.; Moo-Puc, R.; Hern\u00e1ndez-Nu\u00f1ez, E. Synthesis of benzologues of nitazoxanide and tizoxanide: a comparative study of their in vitro broad-spectrum antiprotozoal activity. Bioorg Med Chem Lett 2011,21(10),3168-3171","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"4879","DOI":"10.1016\/j.ejmech.2010.07.060","volume":"45","author":"Goodarzi M.","year":"2010","unstructured":"Goodarzi M.; da Cunha E.F.; Freitas M.P.; Ramalho T.C.; QSAR and docking studies of novel antileishmanial diaryl sulfides and sulfonamides. Eur J Med Chem 2010,45(11),4879-4889","journal-title":"Eur J Med Chem"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"679","DOI":"10.2174\/157018010792929586","volume":"7","author":"da Silva L.E.","year":"2010","unstructured":"da Silva L.E.; de Sousa P.T.; Jr Maciel E.N.; Korting-Nunes R.; Eger I.; Steindel M.; Andrade-Rebelo R.; In vitro antiprotozoal evaluation of zinc and copper complexes based on sulfonamides containing 8-aminoquinoline ligands. Lett Drug Des Discov 2010,7(9),679-685","journal-title":"Lett Drug Des Discov"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1080\/14786410802090359","volume":"23","author":"Khan K.M.","year":"2009","unstructured":"Khan K.M.; Khan M.Z.; Taha M.; Maharvi G.M.; Saify Z.S.; Parveen S.; Choudhary M.I.; Leishmanicidal potential of N-substituted morpholine derivatives: synthesis and structure-activity relationships. Nat Prod Res 2009,23(5),479-484","journal-title":"Nat Prod Res"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"7690","DOI":"10.1016\/j.bmc.2009.09.043","volume":"17","author":"Altenk\u00e4mper M.","year":"2009","unstructured":"Altenk\u00e4mper M.; Bechem B.; Perruchon J.; Heinrich S.; M\u00e4del A.; Ortmann R.; Dahse H.M.; Freunscht E.; Wang Y.; Rath J.; Stich A.; Hitzler M.; Chiba P.; Lanzer M.; Schlitzer M.; Antimalarial and antitrypanosomal activity of a series of amide and sulfonamide derivatives of a 2,5-diaminobenzophenone. Bioorg Med Chem 2009,17(22),7690-7697","journal-title":"Bioorg Med Chem"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"7449","DOI":"10.1016\/j.bmc.2009.09.030","volume":"17","author":"Dea-Ayuela M.A.","year":"2009","unstructured":"Dea-Ayuela M.A.; Castillo E.; Gonz\u00e1lez-\u00c1lvarez M.; Vega C.; Rol\u00f3n M.; Bol\u00e1s-Fern\u00e1ndez F.; Borr\u00e1s J.; Gonz\u00e1lez-Rosende M.E.; In vivo and in vitro anti-leishmanial activities of 4-nitro-N-pyrimidin- and N-pyrazin-2-ylbenzenesulfonamides, and N2-(4-nitrophenyl)-N1-propylglycinamide. Bioorg Med Chem 2009,17(21),7449-7456","journal-title":"Bioorg Med Chem"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.parint.2012.05.015","volume":"61","author":"Bilbao-Ramos P.","year":"2012","unstructured":"Bilbao-Ramos P.; Galiana-Rosell\u00f3 C.; Dea-Ayuela M.A.; Gonz\u00e1lez-Alvarez M.; Vega C.; Rol\u00f3n M.; P\u00e9rez-Serrano J.; Bol\u00e1s-Fern\u00e1ndez F.; Gonz\u00e1lez-Rosende M.E.; Nuclease activity and ultrastructural effects of new sulfonamides with anti-leishmanial and trypanocidal activities. Parasitol Int 2012,61(4),604-613","journal-title":"Parasitol Int"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1016\/j.bmc.2014.01.029","volume":"22","author":"Nava-Zuazo C.","year":"2014","unstructured":"Nava-Zuazo C.; Ch\u00e1vez-Silva F.; Moo-Puc R.; Chan-Bacab M.J.; Ortega-Morales B.O.; Moreno-D\u00edaz H.; D\u00edaz-Couti\u00f1o D.; Hern\u00e1ndez-N\u00fa\u00f1ez E.; Navarrete-V\u00e1zquez G.; 2-acylamino-5-nitro-1,3-thiazoles: preparation and in vitro bioevaluation against four neglected protozoan parasites. Bioorg Med Chem 2014,22(5),1626-1633","journal-title":"Bioorg Med Chem"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1016\/j.bmc.2015.02.059","volume":"23","author":"Navarrete-V\u00e1zquez G.","year":"2015","unstructured":"Navarrete-V\u00e1zquez G.; Ch\u00e1vez-Silva F.; Col\u00edn-Lozano B.; Estrada-Soto S.; Hidalgo-Figueroa S.; Guerrero-\u00c1lvarez J.; M\u00e9ndez S.T.; Reyes-Vivas H.; Oria-Hern\u00e1ndez J.; Canul-Canch\u00e9 J.; Ortiz-Andrade R.; Moo-Puc R.; Synthesis of nitro(benzo)thiazole acetamides and in vitro antiprotozoal effect against amitochondriate parasites Giardia intestinalis and Trichomonas vaginalis. Bioorg Med Chem 2015,23(9),2204-2210","journal-title":"Bioorg Med Chem"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.molbiopara.2013.12.002","volume":"193","author":"Somvanshi V.S.","year":"2014","unstructured":"Somvanshi V.S.; Ellis B.L.; Hu Y.; Aroian R.V.; Nitazoxanide: nematicidal mode of action and drug combination studies. Mol Biochem Parasitol 2014,193(1),1-8","journal-title":"Mol Biochem Parasitol"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1093\/jac\/dkm205","volume":"60","author":"M\u00fcller J.","year":"2007","unstructured":"M\u00fcller J.; Sterk M.; Hemphill A.; M\u00fcller N.; Characterization of Giardia lamblia WB C6 clones resistant to nitazoxanide and to metronidazole. J Antimicrob Chemother 2007,60(2),280-287","journal-title":"J Antimicrob Chemother"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1093\/jac\/dkt106","volume":"68","author":"M\u00fcller J.","year":"2013","unstructured":"M\u00fcller J.; Schildknecht P.; M\u00fcller N.; Metabolism of nitro drugs metronidazole and nitazoxanide in Giardia lamblia: characterization of a novel nitroreductase (GlNR2). J Antimicrob Chemother 2013,68(8),1781-1789","journal-title":"J Antimicrob Chemother"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1107\/S0907444904018955","volume":"60","author":"McLuskey K.","year":"2004","unstructured":"McLuskey K.; Gibellini F.; Carvalho P.; Avery M.A.; Hunter W.N.; Inhibition of Leishmania major pteridine reductase by 2,4,6-triaminoquinazoline: structure of the NADPH ternary complex. Acta Crystallogr D Biol Crystallogr 2004,60(Pt 10),1780-1785","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"2637","DOI":"10.1016\/j.bmc.2005.01.025","volume":"13","author":"Khabnadideh S.","year":"2005","unstructured":"Khabnadideh S.; Pez D.; Musso A.; Brun R.; P\u00e9rez L.M.; Gonz\u00e1lez-Pacanowska D.; Gilbert I.H.; Design, synthesis and evaluation of 2,4-diaminoquinazolines as inhibitors of trypanosomal and leishmanial dihydrofolate reductase. Bioorg Med Chem 2005,13(7),2637-2649","journal-title":"Bioorg Med Chem"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.pt.2003.09.008","volume":"19","author":"Croft S.L.","year":"2003","unstructured":"Croft S.L.; Coombs G.H.; Leishmaniasis-current chemotherapy and recent advances in the search for novel drugs. Trends Parasitol 2003,19(11),502-508","journal-title":"Trends Parasitol"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.exppara.2011.01.009","volume":"127","author":"Estevez Y.","year":"2011","unstructured":"Estevez Y.; Quiliano M.; Burguete A.; Cabanillas B.; Zimic M.; M\u00e1laga E.; Ver\u00e1stegui M.; P\u00e9rez-Silanes S.; Aldana I.; Monge A.; Castillo D.; Deharo E.; Trypanocidal properties, structure-activity relationship and computational studies of quinoxaline 1,4-di-N-oxide derivatives. Exp Parasitol 2011,127(4),745-751","journal-title":"Exp Parasitol"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"3624","DOI":"10.1021\/jm2002469","volume":"54","author":"Benitez D.","year":"2011","unstructured":"Benitez D.; Cabrera M.; Hern\u00e1ndez P.; Boiani L.; Lavaggi M.L.; Di Maio R.; Yaluff G.; Serna E.; Torres S.; Ferreira M.E.; Vera de Bilbao N.; Torres E.; P\u00e9rez-Silanes S.; Solano B.; Moreno E.; Aldana I.; L\u00f3pez de Cer\u00e1in A.; Cerecetto H.; Gonz\u00e1lez M.; Monge A.; 3-Trifluoromethylquinoxaline N,N\u2032-dioxides as anti-trypanosomatid agents. Identification of optimal anti-T. cruzi agents and mechanism of action studies. J Med Chem 2011,54(10),3624-3636","journal-title":"J Med Chem"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"4120","DOI":"10.1007\/s00044-011-9955-z","volume":"21","author":"Varela J.","year":"2012","unstructured":"Varela J.; Lessa J.A.; Lavaggi M.L.; Beraldo H.; Cerecetto H.; Gonzalez M.; Coordination of 3-aminoquino-xaline-2-carbonitrile 1,4-dioxides to antimony (III) as a strategy for anti-Trypanosoma cruzi activity improvement. Med Chem Res 2012,21(12),4120-4128","journal-title":"Med Chem Res"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"4498","DOI":"10.1016\/j.bmcl.2011.05.125","volume":"21","author":"Barea C.","year":"2011","unstructured":"Barea C.; Pab\u00f3n A.; Castillo D.; Zimic M.; Quiliano M.; Galiano S.; P\u00e9rez-Silanes S.; Monge A.; Deharo E.; Aldana I.; New salicylamide and sulfonamide derivatives of quinoxaline 1,4-di-N-oxide with antileishmanial and antimalarial activities. Bioorg Med Chem Lett 2011,21(15),4498-4502","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"4718","DOI":"10.3390\/molecules18044718","volume":"18","author":"Barea C.","year":"2013","unstructured":"Barea C.; Pab\u00f3n A.; P\u00e9rez-Silanes S.; Galiano S.; Gonzalez G.; Monge A.; Deharo E.; Aldana I.; New amide derivatives of quinoxaline 1,4-di-N-oxide with leishmanicidal and antiplasmodial activities. Molecules 2013,18(4),4718-4727","journal-title":"Molecules"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.ejmech.2015.04.028","volume":"96","author":"Mendoza-Mart\u00ednez C.","year":"2015","unstructured":"Mendoza-Mart\u00ednez C.; Correa-Basurto J.; Nieto-Meneses R.; M\u00e1rquez-Navarro A.; Aguilar-Su\u00e1rez R.; Montero-Cortes M.D.; Nogueda-Torres B.; Su\u00e1rez-Contreras E.; Galindo-Sevilla N.; Rojas-Rojas \u00c1.; Rodriguez-Lezama A.; Hern\u00e1ndez-Luis F.; Design, synthesis and biological evaluation of quinazoline derivatives as anti-trypano-somatid and anti-plasmodial agents. Eur J Med Chem 2015,96,296-307","journal-title":"Eur J Med Chem"},{"key":"ref=119","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0085706","volume":"9","author":"Rodrigues J.H.S.","year":"2014","unstructured":"Rodrigues J.H.S.; Ueda-Nakamura T.; Corr\u00eaa A.G.; Sangi D.P.; Nakamura C.V.; A quinoxaline derivative as a potent chemotherapeutic agent, alone or in combination with benznidazole, against Trypanosoma cruzi. PLoS One 2014,9(1)","journal-title":"PLoS One"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.ejmech.2014.11.018","volume":"90","author":"Cogo J.","year":"2015","unstructured":"Cogo J.; Kaplum V.; Sangi D.P.; Ueda-Nakamura T.; Corr\u00eaa A.G.; Nakamura C.V.; Synthesis and biological evaluation of novel 2,3-disubstituted quinoxaline derivatives as antileishmanial and antitrypanosomal agents. Eur J Med Chem 2015,90,107-123","journal-title":"Eur J Med Chem"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929867327666200303170000","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/179917\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929867327666200303170000","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T14:34:57Z","timestamp":1660055697000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/179917\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":120,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929867327666200303170000","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2019-07-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-11-05","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-01-01","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-02-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}